Jianxin Xue

11PUBLICATIONS
44CO-AUTHORS
Metal organic frameworksApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Radiation therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 06, 2026
Biomimetic Synthesis of Multinuclear Metal-Oxo Bridges Under Mild Aqueous Conditions for Catalytic Cancer Therapy.

|Jul 08, 2026
SBRT embedded in low-dose RT plus αPD-1 (immuno-EclipseRT, iERT) elicits CD8+ T cell immunity against bulky tumors via an IFN-I/NK/DC axis.

|Jun 09, 2026
Tumor-Regional Immune Microenvironment: A Critical Factor in the Design of Radiotherapy-Immunotherapy Combination Trials.

|Oct 21, 2025
Drug allergy history predicts early progression-free survival benefit from PD-(L)1 inhibitors in advanced non-small cell lung cancer: a retrospective cohort study.

Wenhao Zhao, Min Yu, Youling Gong

|Sep 18, 2025
[The Role of Fasting-Mimicking Diet in Cancer Therapy: Mechanisms, Challenges, and Clinical Prospects].

Yuanxin Liu, Laiyan Zhou, Jianxin Xue

|Sep 09, 2024
Cell Identity and Spatial Distribution of PD-1/PD-L1 Blockade Responders.

Xintong Li, Yuanxin Liu, Jun Gui

Pageof 2

Frequent Collaborators

3 joint publications

You Lu

3 joint publications

Min Yu

2 joint publications

Ren Luo

2 joint publications

Laiyan Zhou